Quoin Pharmaceuticals, Ltd. (QNRX) NASDAQ
4.56
-0.2101(-4.40%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Quoin Pharmaceuticals, Ltd.
Address
42127 Pleasant Forest Court
Ashburn, VA 20148-7349
United States of America (the)
Phone
703 980 4182
Website
Sector
Healthcare
Industry
Biotechnology
Employees
3
First IPO Date
August 01, 2016
Key Executives
| Name | Title | Pay | Year Born |
| Michael Myers | Co-Founder, Chief Executive Officer & Chairman | 1.18M | 1962 |
| Sally Lawlor | Chief Financial Officer | 539,697 | 1983 |
| Denise Carter | Co-Founder, Chief Operating Officer & Director | 951,000 | 1969 |
Description
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
